Intraplaque neovascularization and hemorrhage: Markers for cardiovascular risk stratification and therapeutic monitoring

Journal of Cardiovascular Medicine

Volumn 13, Issue 10, 2012, Pages 635-639

  Koole, Dave ^a,b   Heyligers, Jan ^c   Moll, Frans L ^a   Pasterkamp, Gerard ^b  

^a Department of Vascular Surgery ^*  (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c Microvida Laboratory for Medical Microbiology and Immunology   (Netherlands)

Author keywords

Atherosclerosis; biobank; cardiovascular events; intraplaque hemorrhage; intraplaque neovascularization

Indexed keywords

ANTILIPEMIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SCATTER FACTOR; VASCULOTROPIN;

ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; BLEEDING; CARDIOVASCULAR RISK; CONTRAST ENHANCEMENT; DISEASE COURSE; ECHOGRAPHY; HISTOPATHOLOGY; HUMAN; INTRAPLAQUE HEMORRHAGE; INTRAPLAQUE NEOVASCULARIZATION; NON INVASIVE PROCEDURE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; VASA VASORUM;

ANIMALS; ARTERIES; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; DIAGNOSTIC IMAGING; DISEASE PROGRESSION; HEMORRHAGE; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; PLAQUE, ATHEROSCLEROTIC; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; RUPTURE, SPONTANEOUS;

EID: 84866348559     PISSN: 15582027     EISSN: 15582035     Source Type: Journal    
DOI: 10.2459/JCM.0b013e3283590cd2     Document Type: Review

References (65)

1. Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet 1997; 349:1436-1442.
2. Tuzcu EM, Kapadia SR, Tutar E, et al. High prevalence of coronary atherosclerosis in asymptomatic teenagers and young adults: evidence from intravascular ultrasound. Circulation 2001; 103:2705-2710.
3. Davies MJ. Stability and instability: two faces of coronary atherosclerosis. The Paul Dudley White Lecture 1995. Circulation 1996; 94:2013-2020.
4. Michel JB, Virmani R, Arbustini E, Pasterkamp G. Intraplaque haemorrhages as the trigger of plaque vulnerability. Eur Heart J 2011; 32:1977-1985, 1985a, 1985b, 1985c.
5. Staub D, Patel MB, Tibrewala A, et al. Vasa vasorum and plaque neovascularization on contrast-enhanced carotid ultrasound imaging correlates with cardiovascular disease and past cardiovascular events. Stroke 2010; 41:41-47.
6. Altaf N, MacSweeney ST, Gladman J, Auer DP. Carotid intraplaque hemorrhage predicts recurrent symptoms in patients with high-grade carotid stenosis. Stroke 2007; 38:1633-1635.
7. Hellings WE, Peeters W, Moll FL, et al. Composition of carotid atherosclerotic plaque is associated with cardiovascular outcome: a prognostic study. Circulation 2010; 121:1941-1950.
8. Singh N, Moody AR, Gladstone DJ, et al. Moderate carotid artery stenosis: MR imaging-depicted intraplaque hemorrhage predicts risk of cerebrovascular ischemic events in asymptomatic men. Radiology 2009; 252:502-508.
9. Smulders YM, Thijs A, Twisk JW. New cardiovascular risk determinants do exist and are clinically useful. Eur Heart J 2008; 29:436-440.
10. van Lammeren GW, de Vries JP, Vink A, de Kleijn DP, Moll FL, Pasterkamp G. New predictors of adverse cardiovascular events following vascular surgery. Semin Cardiothorac Vasc Anesth 2010; 14:148-153.
11. Kö ester W. Endarteriits and arteriitis. Berl Klin Wochenschr 1876; 12:454-455.
12. Barger AC, Beeuwkes R 3rd, Lainey LL, Silverman KJ. Hypothesis: vasa vasorum and neovascularization of human coronary arteries. A possible role in the pathophysiology of atherosclerosis. N Engl J Med 1984; 310:175-177.
13. Sluimer JC, Daemen MJ. Novel concepts in atherogenesis: angiogenesis and hypoxia in atherosclerosis. J Pathol 2009; 218:7-29.
14. Sluimer JC, Gasc JM, van Wanroij JL, et al. Hypoxia, hypoxia-inducible transcription factor, and macrophages in human atherosclerotic plaques are correlated with intraplaque angiogenesis. J Am Coll Cardiol 2008; 51:1258-1265.
15. Virmani R, Kolodgie FD, Burke AP, et al. Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage. Arterioscler Thromb Vasc Biol 2005; 25:2054-2061.
16. Kumamoto M, Nakashima Y, Sueishi K. Intimal neovascularization in human coronary atherosclerosis: its origin and pathophysiological significance. Hum Pathol 1995; 26:450-456.
17. Moulton KS. Angiogenesis in atherosclerosis: gathering evidence beyond speculation. Curr Opin Lipidol 2006; 17:548-555.
18. Sluimer JC, Kolodgie FD, Bijnens AP, et al. Thin-walled microvessels in human coronary atherosclerotic plaques show incomplete endothelial junctions relevance of compromised structural integrity for intraplaque microvascular leakage. J Am Coll Cardiol 2009; 53:1517-1527.
19. Kolodgie FD, Gold HK, Burke AP, et al. Intraplaque hemorrhage and progression of coronary atheroma. N Engl J Med 2003; 349:2316-2325.
20. Miller YI, Shaklai N. Oxidative crosslinking of LDL protein induced by hemin: involvement of tyrosines. Biochem Mol Biol Int 1994; 34:1121-1129.
21. Moreno PR, Purushothaman KR, Fuster V, et al. Plaque neovascularization is increased in ruptured atherosclerotic lesions of human aorta: implications for plaque vulnerability. Circulation 2004; 110:2032-2038.
22. Fleiner M, Kummer M, Mirlacher M, et al. Arterial neovascularization and inflammation in vulnerable patients: early and late signs of symptomatic atherosclerosis. Circulation 2004; 110:2843-2850.
23. McCarthy MJ, Loftus IM, Thompson MM, et al. Angiogenesis and the atherosclerotic carotid plaque: an association between symptomatology and plaque morphology. J Vasc Surg 1999; 30:261-268.
24. Giannoni MF, Vicenzini E, Citone M, et al. Contrast carotid ultrasound for the detection of unstable plaques with neoangiogenesis: a pilot study. Eur J Vasc Endovasc Surg 2009; 37:722-727.
25. Turc G, Oppenheim C, Naggara O, et al. Relationships between recent intraplaque hemorrhage and stroke risk factors in patients with carotid stenosis: the HIRISC study. Arterioscler Thromb Vasc Biol 2012; 32:492-499.
26. Turan TN, Bonilha L, Morgan PS, Adams RJ, Chimowitz MI. Intraplaque hemorrhage in symptomatic intracranial atherosclerotic disease. J Neuroimaging 2011; 21:e159-e161.
27. Hellings WE, Moll FL, De Vries JP, et al. Atherosclerotic plaque composition and occurrence of restenosis after carotid endarterectomy. JAMA 2008; 299:547-554.
28. de Kleijn DP, Moll FL, Hellings WE, et al. Local atherosclerotic plaques are a source of prognostic biomarkers for adverse cardiovascular events. Arterioscler Thromb Vasc Biol 2010; 30:612-619.
29. Peeters W, de Kleijn DP, Vink A, et al. Adipocyte fatty acid binding protein in atherosclerotic plaques is associated with local vulnerability and is predictive for the occurrence of adverse cardiovascular events. Eur Heart J 2011; 32:1758-1768.
30. Peeters W, Moll FL, Vink A, et al. Collagenase matrix metalloproteinase-8 expressed in atherosclerotic carotid plaques is associated with systemic cardiovascular outcome. Eur Heart J 2011; 32:2314-2325.
31. -/~ double knockout mice. Atherosclerosis 2007; 191:73-81.
32. Gisbertz SS, Derksen WJ, de Kleijn DP, et al. The effect of alcohol on atherosclerotic plaque composition and cardiovascular events in patients with arterial occlusive disease. J Vasc Surg 2011; 54:123-131.
33. Nadar SK, Blann A, Beevers DG, Lip GY. Abnormal angiopoietins 1&2, angiopoietin receptor Tie-2 and vascular endothelial growth factor levels in hypertension: relationship to target organ damage [a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)]. J Intern Med 2005; 258:336-343.
34. Siervo M, Ruggiero D, Sorice R, et al. Angiogenesis and biomarkers of cardiovascular risk in adults with metabolic syndrome. J Intern Med 2010; 268:338-347.
35. Abraham D, Hofbauer R, Schafer R, et al. Selective downregulation of VEGF-A(165), VEGF-R(1), and decreased capillary density in patients with dilative but not ischemic cardiomyopathy. Circ Res 2000; 87:644-647.
36. Izumiya Y, Shiojima I, Sato K, Sawyer DB, Colucci WS, Walsh K. Vascular endothelial growth factor blockade promotes the transition from compensatory cardiac hypertrophy to failure in response to pressure overload. Hypertension 2006; 47:887-893.
37. Post S, Peeters W, Busser E, et al. Balance between angiopoietin-1 and angiopoietin-2 is in favor of angiopoietin-2 in atherosclerotic plaques with high microvessel density. J Vasc Res 2008; 45:244-250.
38. Pitsilos S, Hunt J, Mohler ER, et al. Platelet factor 4 localization in carotid atherosclerotic plaques: correlation with clinical parameters. Thromb Haemost 2003; 90:1112-1120.
39. Wang Y, Zheng Y, Zhang W, et al. Polymorphisms of KDR gene are associated with coronary heart disease. J Am Coll Cardiol 2007; 50:760-767.
40. Corsetti JP, Ryan D, Moss AJ, et al. Thrombospondin-4 polymorphism (A387P) predicts cardiovascular risk in postinfarction patients with high HDL cholesterol and C-reactive protein levels. Thromb Haemost 2011; 106:1170-1178.
41. Heeschen C, Dimmeler S, Fichtlscherer S, et al. Prognostic value of placental growth factor in patients with acute chest pain. JAMA 2004; 291:435-441.
42. LenderinkT, Heeschen C, Fichtlscherer S, et al. Elevated placental growth factor levels are associated with adverse outcomes at four-year follow-up in patients with acute coronary syndromes. J Am Coll Cardiol 2006; 47:307-311.
43. Theilade S, Lajer M, Jorsal A, Tarnow L, Parving HH, Rossing P. Evaluation of placental growth factor and soluble Fms-like tyrosine kinase 1 as predictors of all-cause and cardiovascular mortality in patients with Type 1 diabetes with and without diabetic nephropathy. Diabet Med 2012; 29:337-344.
44. Susen S, Sautiere K, Mouquet F, et al. Serum hepatocyte growth factor levels predict long-term clinical outcome after percutaneous coronary revascularization. Eur Heart J 2005; 26:2387-2395.
45. Derksen WJ, Peeters W, Tersteeg C, et al. Age and coumarin-type anticoagulation are associated with the occurrence of intraplaque hemorrhage, while statins are associated less with intraplaque hemorrhage: a large histopathological study in carotid and femoral plaques. Atherosclerosis 2011; 214:139-143.
46. Koutouzis M, Nomikos A, Nikolidakis S, et al. Statin treated patients have reduced intraplaque angiogenesis in carotid endarterectomy specimens. Atherosclerosis 2007; 192:457-463.
47. Wilson SH, Herrmann J, Lerman LO, et al. Simvastatin preserves the structure of coronary adventitial vasa vasorum in experimental hypercholesterolemia independent of lipid lowering. Circulation 2002; 105:415-418.
48. Leithauser B, Mrowietz C, Hiebl B, Pindur G, Jung F. Capillary bleeding under oral anticoagulation. Clin Hemorheol Microcirc 2009; 43:167-171.
49. Staub D, Schinkel AF, Coll B, et al. Contrast-enhanced ultrasound imaging of the vasa vasorum: from early atherosclerosis to the identification of unstable plaques. JACC Cardiovasc Imaging 2010; 3:761-771.
50. Granada JF, Feinstein SB. Imaging of the vasa vasorum. Nat Clin Pract Cardiovasc Med 2008; 5 (Suppl 2):S18-S25.
51. Coll B, Nambi V, Feinstein SB. New advances in noninvasive imaging of the carotid artery: CIMT, contrast-enhanced ultrasound, and vasa vasorum. Curr Cardiol Rep 2010; 12:497-502.
52. ten Kate GL, Sijbrands EJ, Valkema R, et al. Molecular imaging of inflammation and intraplaque vasa vasorum: a step forward to identification of vulnerable plaques? J Nucl Cardiol 2010; 17:897-912.
53. Slevin M, Badimon L, Grau-Olivares M, et al. Combining nanotechnology with current biomedical knowledge for the vascular imaging and treatment of atherosclerosis. Mol Biosyst 2010; 6:444-450.
54. Takaya N, Yuan C, Chu B, et al. Presence of intraplaque hemorrhage stimulates progression of carotid atherosclerotic plaques: a high-resolution magnetic resonance imaging study. Circulation 2005; 111:2768-2775.
55. Kerwin W, Hooker A, Spilker M, et al. Quantitative magnetic resonance imaging analysis of neovasculature volume in carotid atherosclerotic plaque. Circulation 2003; 107:851-856.
56. Sirol M, Moreno PR, Purushothaman KR, et al. Increased neovascularization in advanced lipid-rich atherosclerotic lesions detected by gadofluorine-M- enhanced MRI: implications for plaque vulnerability. Circ Cardiovasc Imaging 2009; 2:391-396.
57. Cornily JC, Hyafil F, Calcagno C, et al. Evaluation of neovessels in atherosclerotic plaques of rabbits using an albumin-binding intravascular contrast agent and MRI. J Magn Reson Imaging 2008; 27:1406-1411.
58. Feinstein SB, Coll B, Staub D, et al. Contrast enhanced ultrasound imaging. J Nucl Cardiol 2010; 17:106-115.
59. Moguillansky D, Leng X, Carson A, et al. Quantification of plaque neovascularization using contrast ultrasound: a histologic validation. Eur Heart J 2011; 32:646-653.
60. Dong L, Kerwin WS, Chen H, et al. Carotid artery atherosclerosis: effect of intensive lipid therapy on the vasa vasorum: evaluation by using dynamic contrast-enhanced MR imaging. Radiology 2011; 260:224-231.
61. Feinstein SB. Contrast ultrasound imaging of the carotid artery vasa vasorum and atherosclerotic plaque neovascularization. J Am Coll Cardiol 2006; 48:236-243.
62. Decano JL, Moran AM, Ruiz-Opazo N, Herrera VL. Molecular Imaging of vasa vasorum neovascularization via DEspR-targeted contrast-enhanced ultrasound micro-imaging in transgenic atherosclerosis rat model. Mol Imaging Biol 2011; 13:1096-1106.
63. Winter PM, Neubauer AM, Caruthers SD, et al. Endothelial alpha(v)beta3 integrin-targeted fumagillin nanoparticles inhibit angiogenesis in atherosclerosis. Arterioscler Thromb Vasc Biol 2006; 26:2103-2109.
64. Winter PM, Caruthers SD, Zhang H, Williams TA, Wickline SA, Lanza GM. Antiangiogenic synergism of integrin-targeted fumagillin nanoparticles and atorvastatin in atherosclerosis. JACC Cardiovasc Imaging 2008; 1:624-634.
65. den Hartog AG, Bovens SM, Koning W, et al. PLACD-7T Study: atherosclerotic carotid plaque components correlated with cerebral damage at 7 Tesla magnetic resonance imaging. Curr Cardiol Rev 2011; 7:28-34.